Edit Tóth‐Molnár

University of Szeged — Hungary

Medicine · Health Sciences

16h-index1.1kcitations84works11.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ocular Surface and Contact Lens(16), Retinal Diseases and Treatments(12), Retinal and Optic Conditions(10), Cutaneous Melanoma Detection and Management(9), Ocular Oncology and Treatments(9)

Publications82 total

Acute effects of intravitreal aflibercept injections on intraocular pressure in vitrectomized and silicone-oil-filled eyes: a prospective cohort study
Scientific Reports·2026Open Access
Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
JAMA Ophthalmology·2025Open Access
Sub-tenon triamcinolon-acetonid kezelés gyermekkori uveitises esetekben
Szemészet·2025Open Access
Számítógépprogram a lencsedőlés elülső szegmens OCT-felvételek alapján történő meghatározására
Szemészet·2025Open Access
The D15 color arrangement test retains its diagnostic value regardless of display accuracy: A modeling study
2024· 1 citedOpen Access
The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid‐periocular basal cell carcinoma: long‐term results
International Journal of Dermatology·2024· 3 citedOpen Access
The effect of cumulative energy in repeated subliminal transscleral cyclophotocoagulation: a retrospective study
BMC Ophthalmology·2024Open Access
The Role of Aquaporin 4 in Lacrimal Gland Ductal Fluid Secretion in Mice
Investigative Ophthalmology & Visual Science·2024· 2 citedOpen Access
Sources of Variance in Human Tear Proteomic Samples: Statistical Evaluation, Quality Control, Normalization, and Biological Insight
International Journal of Molecular Sciences·2024· 5 citedOpen Access
Subfovealisan rekedt perfluorodecalin műtéti megoldása
Szemészet·2024Open Access
Biológiai terápia szerepe a nem fertőzéses eredetű uveitisek kezelésében : A dél-alföldi régióban adalimumabbal kezelt betegek eredményei
Szemészet·2024Open Access
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial
BMJ Open Ophthalmology·2023· 13 citedOpen Access
Long-Term Follow-Up of a Family with Retinal Dystrophy Caused by RPE65 Mutation
Case Reports in Ophthalmology·2023· 1 citedOpen Access
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
The Lancet·2023· 266 citedOpen Access
Optical Coherence Tomography: Focus on the Pathology of Macula in Scleritis Patients
Journal of Clinical Medicine·2023· 5 citedOpen Access
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration
JAMA Ophthalmology·2023· 27 citedOpen Access
Paediatric dermatological research at the Department of Dermatology and Allergology of the University of Szeged between 2004-2023
Bőrgyógyászati és Venerológiai Szemle·2023Open Access
Milestones of electrochemotherapy
Bőrgyógyászati és Venerológiai Szemle·2023Open Access
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
Japanese Journal of Ophthalmology·2023· 17 citedOpen Access
Új fejezet a szemfelszín gyulladásos betegségeinek kezelésében: „soft” típusú topikális szteroid a gyulladáscsökkentő terápiás algoritmusban
Szemészet·2023· 3 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Judit Oláh(9), Eszter Vizvári(9), Lajos Kemény(7), Chuanqing Ding(6), Helga Hammer(5), Attila Vass(4), Adrienne Csutak(4), Orsolya Berczeli(4), Máté Katona(4), L. Szalay(4), Péter Hegyi(4), Huba Kalász(4), Ramin Tadayoni(3), Mario Bradvica(3), Jan Ernest(3), Zsanett Csoma(3), Hajnalka Orvos(3), Erika Kis(3), A. Dobozy(3), Attila Vajas(3)